• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid: A Comprehensive Overview

2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid, also known by its CAS number 1272301-61-7, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidine derivatives, which are widely studied due to their potential applications in drug discovery and development. The structure of this molecule consists of a pyrimidine ring system with substituents at positions 2, 4, and 6. Specifically, the 2-position is substituted with a 4-chlorophenyl group, the 4-position bears a carboxylic acid group, and the 6-position is substituted with a methyl group. These substituents play a crucial role in determining the compound's chemical properties, biological activity, and potential therapeutic applications.

The synthesis of 2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid involves a series of well-established organic reactions. Typically, the starting material is a pyrimidine derivative, which undergoes substitution or coupling reactions to introduce the desired substituents. The introduction of the 4-chlorophenyl group at position 2 is often achieved through nucleophilic aromatic substitution or coupling reactions such as Suzuki-Miyaura cross-coupling. The carboxylic acid group at position 4 can be introduced via oxidation of an alcohol or through direct synthesis using appropriate precursors. The methyl group at position 6 is typically introduced during the initial stages of pyrimidine synthesis or through alkylation reactions.

Recent studies have highlighted the potential of pyrimidine derivatives as inhibitors of various enzymes and receptors involved in disease pathways. For instance, research has shown that 2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid exhibits inhibitory activity against certain kinases, making it a promising candidate for anti-cancer drug development. Additionally, this compound has been investigated for its potential anti-inflammatory and neuroprotective properties, which could make it useful in treating conditions such as Alzheimer's disease and chronic inflammatory disorders.

The biological activity of 2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid is closely related to its molecular structure. The presence of the chlorophenyl group at position 2 enhances the compound's lipophilicity, which may improve its ability to cross cellular membranes and bind to target proteins. The carboxylic acid group at position 4 contributes to hydrogen bonding capabilities, which are essential for interactions with biological targets. Furthermore, the methyl group at position 6 may influence the compound's stability and metabolic profile, making it more suitable for pharmacological applications.

In terms of applications, 2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid has been explored as a lead compound in drug discovery programs targeting various diseases. Its ability to modulate key biological pathways makes it a valuable tool for researchers in academia and industry alike. Ongoing studies are focused on optimizing its pharmacokinetic properties, improving its bioavailability, and identifying its mechanism of action in vivo.

In conclusion, 2-(4-Chlorophenyl)-6-Methylpyrimidine-4-Carboxylic Acid, with its unique structural features and promising biological activities, represents an important compound in contemporary medicinal chemistry. Its potential applications span across multiple therapeutic areas, making it a subject of intense research interest. As advancements in synthetic methodologies and biological screening continue to evolve, this compound is likely to play an increasingly significant role in the development of novel therapeutic agents.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)